↓ Skip to main content

PI3K/AKT/mTOR inhibitors for advanced or recurrent endometrial cancer

Overview of attention for article published in Cochrane database of systematic reviews, October 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (80th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

policy
1 policy source
twitter
7 X users
facebook
1 Facebook page
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
65 Dimensions

Readers on

mendeley
149 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
PI3K/AKT/mTOR inhibitors for advanced or recurrent endometrial cancer
Published in
Cochrane database of systematic reviews, October 2019
DOI 10.1002/14651858.cd012160.pub2
Pubmed ID
Authors

Felicia Roncolato, Kristina Lindemann, Melina L Willson, Julie Martyn, Linda Mileshkin

X Demographics

X Demographics

The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 149 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 149 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 16 11%
Student > Bachelor 16 11%
Researcher 10 7%
Student > Doctoral Student 8 5%
Student > Ph. D. Student 7 5%
Other 21 14%
Unknown 71 48%
Readers by discipline Count As %
Medicine and Dentistry 34 23%
Nursing and Health Professions 11 7%
Biochemistry, Genetics and Molecular Biology 10 7%
Pharmacology, Toxicology and Pharmaceutical Science 7 5%
Psychology 3 2%
Other 11 7%
Unknown 73 49%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 May 2022.
All research outputs
#3,642,374
of 25,595,500 outputs
Outputs from Cochrane database of systematic reviews
#6,354
of 13,156 outputs
Outputs of similar age
#72,588
of 366,069 outputs
Outputs of similar age from Cochrane database of systematic reviews
#114
of 193 outputs
Altmetric has tracked 25,595,500 research outputs across all sources so far. Compared to these this one has done well and is in the 85th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,156 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.8. This one has gotten more attention than average, scoring higher than 51% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 366,069 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 80% of its contemporaries.
We're also able to compare this research output to 193 others from the same source and published within six weeks on either side of this one. This one is in the 41st percentile – i.e., 41% of its contemporaries scored the same or lower than it.